Nabriva Therapeutics : Failure to Satisfy Listing Rule
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT ...
Dublin City United States David Maggio Group Inc Exchange Commission Company Quarterly Report On Form
Source: marketscreener.com